John B. Moriarty - Aug 1, 2024 Form 4 Insider Report for Avidity Biosciences, Inc. (RNA)

Signature
/s/ Michael F. MacLean, Attorney-in-Fact
Stock symbol
RNA
Transactions as of
Aug 1, 2024
Transactions value $
$0
Form type
4
Date filed
8/5/2024, 09:11 AM
Previous filing
Jan 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNA Common Stock Award $0 +25K $0.00 25K Aug 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNA Stock Option (Right to Buy) Award $0 +160K $0.00 160K Aug 1, 2024 Common Stock 160K $44.57 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in four equal installments on the first four anniversaries of August 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
F2 1/4th of the total number of shares subject to the options shall vest on the first anniversary of August 1, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the fourth anniversary of the Vesting Commencement Date.